GPC3 and liver cancer: The N-leaf cysteine-rich domain (CRD) of GPC3 has a Wnt-binding groove, and the mutation of the notch reduces binding, thereby reducing Wnt activation, and inhibiting the growth of mouse liver cancer (43).